Sitemap - 2023 - HERV-K102 and Pandemic Responses

Data From OECD Suggests Canada Topped the % Excess All-Cause Mortality of Any OECD Country in 2023

Excess All-Cause Mortality for Canada Predicts Dire Straits for 2023?

Revision of Preprint on "Antibody Dependent Enhancement (ADE) of Infection into Macrophages Validates the Importance of HERV-K102 Particle Production for Pandemic Preparedness" (i.e., v.2)

Preprint Now Available Describing the VIRUS - Anti-Virus Protection System of Human Macrophages {HERV-K102/Trained (innate) Immunity}

Predictions by Dr. Geert Vanden Bossche Came True

On the Subject of Turbo Cancers

World Council for Health Emergency Meeting Monday October 9 at 2pm (EST)

Pfizer Vaccines with Oncogenic SV40 DNA Contamination Not Revealed to FDA

How to Distinguish Turbo Cancers

Trends in Symptoms with Serious Adverse Events of the mRNA COVID-19 Vaccines

Natural Immunity is Similar Albeit Better than the Third Dose (Tolerizing) COVID-19 Vaccine for All-Cause Mortality in the Aged

Failed Surveillance and Risk Assessment of COVID-19 Vaccines in Canada

A Call to Arms

Open Letter on the Safety and Effectiveness of the COVID-19 Vaccines

I don’t think this is a case of healthy vaccinee bias.

Trained immunity involving HERV-K102 activation in foamy macrophages may promote recovery from COVID-19 providing a new innate immunity vaccination paradigm against pandemic RNA viruses

When will the sudden adult death syndrome (SADS) end?

Ivermectin May Defeat Cancer and Other Common Chronic Diseases of Aging

The END of the Natural Health Product (NHP) Industry in Canada Unless YOU Act

Countermeasures injury compensation program for the USA response to COVID-19 woefully inadequate

Is the Conversion of IgG1/3 to IgG4 a GOOD or BAD Thing?

Key Differences of Innate & Adaptive Immunity for Handling Pandemics

More Evidence that Innate Neutralizing Antibodies to HERV-K102 Envelope Contribute to COVID-19 Protection and "In Vitro Neutralizing Titres" in HUMANS Depending on the Methods Used

The Important Differences Between Innate and Adaptive Immunity for Pandemics

Imprinting versus ADE in terms of COVID-19 Vaccine Negative Effectiveness

Excess Non-COVID-19 Death Counts For the 50+ in the UK, (from January 1, 2021 to May 31, 2022) at 1/51

New ONS Data on Mortality Rates by Vaccination Status Released Today

Dr. Fauci... You have replied to my letter of May 6, 2020 ... a little too late

Access to My Ph.D. Thesis on Apoptosis

Why the significance of HERV-K102 as a protector virus against pandemic viruses is ignored.

No Neutralizing Monoclonal Antibodies to Spike Protein Left: Time to Clone and Produce Humanized Innate Immunity Monoclonal Neutralizing Antibodies to HERV-K102 Envelope Protein

PHAC/HC COVID-19 VAX Serious Adverse Event Reporting

CDC Denies Performing Safety Analyses of COVID-19 Vaccines which would have Stopped the Mass Vaccination Campaign

Confusion About the Significance of IgG4 Isotype Dominance of Anti-Spike IgG Antibodies Associated with Serial Immunization with COVID-19 Vaccines:

Comments for upcoming VRBAC Meeting Jan 26 2023